US$ 26.43
glp 1 drugs non injectable New GLP-1 Guidelines for Type 2 Diabetes in 2025 GLP-1 receptor agonists | How
Description
& Tomasevic, G

Collaborative Network database of adults aged 18 years and older with type 2 diabetes who were prescribed tirzepatide (Mounjaro, Eli Lilly) or a GLP-1 receptor agonist from June 1, 2022, to June 20, 2023

Diabet Med

Originally used to treat type 2 diabetes, GLP1 medications are now also widely used for weight management
If developed, pancreatobiliary complications should be managed according to the guidelines of each centre

Current Medicinal Chemistry
